Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Turn Therapeutics Inc.TTRX · Entity 5935 | Board Observer | October 23, 2025 | October 29, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Turn Therapeutics Inc.
Report date October 23, 2025 · Filed October 29, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy ANC Merchant FLP and ANC Carlson FLP | 1,447,268 |
Reported balance
After 2025-10-23 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2025-10-23 · Purchase · Acquired 14,286 · Balance 1,447,268 F1: Shares are held indirectly through ANC Merchant FLP and ANC Carlson FLP, each owned 48% by the reporting person, 48% by the reporting person's spouse, and 2% by each of the reporting person's two children; the reporting person disclaims beneficial ownership of the shares attributable to his spouse except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares are held indirectly through ANC Merchant FLP and ANC Carlson FLP, each owned 48% by the reporting person, 48% by the reporting person's spouse, and 2% by each of the reporting person's two children; the reporting person disclaims beneficial ownership of the shares attributable to his spouse except to the extent of his pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 23, 2025 Filed Oct 29, 2025 20:43 UTC | Turn Therapeutics Inc. TTRX · Entity 5935 | PurchaseCommon Stock | 14,286 | $4.60 | $65,715.60 |
DisclosureSEC source: 0001104659-25-103894 · tm2529794-1_4seq1.xml · nonDerivative · entry 1 Chesed Abraham · CIK 0002094374 · Board Observer 10b5-1 filing: No plan indicated Ownership: Indirect · By ANC Merchant FLP and ANC Carlson FLP Disclosed balance after: 1,447,268 F1 · ownership.nature: Shares are held indirectly through ANC Merchant FLP and ANC Carlson FLP, each owned 48% by the reporting person, 48% by the reporting person's spouse, and 2% by each of the reporting person's two children; the reporting person disclaims beneficial ownership of the shares attributable to his spouse except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.